Respiratory-care technology and company updates
Evidence-based summaries for product developers, distributors and healthcare partners.
Why MMAD remains central to nebulizer performance evaluation
Mass Median Aerodynamic Diameter describes the aerodynamic size distribution of an aerosol. Together with output rate, residual volume and treatment time, it helps buyers compare how a nebulizer generates respirable particles. A published comparison of a vibrating-mesh device and jet nebulizers measured inhaled mass, residual activity, MMAD and run time, and also found that device orientation affected mesh-nebulizer run time and particle-distribution variability.
This summary is for product education and does not provide medical advice or replace model-specific testing.
Source: PubMed — Comparison between vibrating mesh and jet nebulizers ↗FDA recognizes ISO 27427:2023 for nebulizing systems
The FDA’s recognized consensus-standards database lists ISO 27427:2023 for general-purpose nebulizing systems and components. Its scope includes gas-powered, ultrasonic, electrically powered and vibrating-mesh systems, and covers safety and performance testing considerations. Manufacturers and procurement teams should still confirm the standards and regulatory requirements that apply to each intended market and product configuration.
Source: U.S. FDA Recognized Consensus Standards ↗Aerosol delivery depends on the complete respiratory circuit
An open-access in-vitro study evaluated nebulizer position, humidification source and simulated lung condition during adult and pediatric invasive mechanical ventilation. The results reinforce that aerosol delivery is a system-level outcome: device type, placement, humidification, patient model and circuit components can all matter. Product specifications should therefore be interpreted alongside the intended interface and use environment.
Source: PubMed Central — Respiratory circuit setup and aerosol delivery ↗Clinical deposition study compares mesh and jet configurations
A small randomized crossover study in healthy adults compared a jet nebulizer alone, a jet nebulizer with a valved holding chamber and a mesh nebulizer with a holding chamber. The mesh configuration produced higher measured pulmonary deposition in that study. The result applies to the tested devices and setup and should not be generalized to every model or medication.
Source: PubMed Central — Aerosol lung deposition study ↗Editorial policy
BIOCEEN rewrites technical news in its own words and links to the original public source. Research summaries describe the cited study only; they are not treatment recommendations. Product claims must be supported by the final model datasheet and applicable regulatory documentation.
Key takeaways
- MMAD, aerosol output, residual volume and treatment time should be evaluated together.
- Nebulizer performance depends on the device, interface, position and intended use environment.
- Buyers should verify current standards, model datasheets and destination-market requirements.
